參考資料
1. Manor, I., et al. "The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension." European Psychiatry27.5 (2012): 335-342.
2. Manor, I., et al. "Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension." European Psychiatry 28.6 (2013): 386-391.
3. Vakhapova, V., Cohen, T., Richter, Y., Herzog, Y., & Korczyn, A. D. (2010). Phosphatidylserine containing ω–3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: A double-blind placebo-controlled trial. Dementia and geriatric cognitive disorders, 29(5), 467-474.
4. Vakhapova, V., Richter, Y., Cohen, T., Herzog, Y., & Korczyn, A. D. (2011). Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension. BMC neurology, 11(1), 79.